Canandaigua National Corp’s AbbVie ABBV Stock Holding History

Canandaigua National Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.09M	Buy	+27,988	New	+$6.21M	0.54%	40
2022 Q4	$4.71M	Sell	29,149 -629	-2%	-$96.4K	0.8%	32
2022 Q3	$4M	Sell	29,778 -164	-0.5%	-$23.5K	0.71%	39
2022 Q2	$4.59M	Sell	29,942 -271	-0.9%	-$41.4K	0.81%	34
2022 Q1	$4.9M	Sell	30,213 -1,437	-5%	-$209K	0.75%	41
2021 Q4	$4.29M	Sell	31,650 -361	-1%	-$42.6K	0.63%	46
2021 Q3	$3.45M	Buy	32,011 +2,435	+8%	+$278K	0.56%	54
2021 Q2	$3.33M	Buy	29,576 +14	+0%	+$1.58K	0.54%	56
2021 Q1	$3.2M	Sell	29,562 -431	-1%	-$46.1K	0.54%	57
2020 Q4	$3.21M	Buy	29,993 +231	+0.8%	+$22.2K	0.56%	55
2020 Q3	$2.61M	Sell	29,762 -2,878	-9%	-$271K	0.46%	66
2020 Q2	$3.21M	Buy	+32,640	New	+$2.87M	0.59%	52

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canandaigua National Corp's ABBV Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in AbbVie (ABBV) in Q1 2026: 27,988 shares worth $6.09M. The stake represents 0.54% of the portfolio and ranks #40 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in ABBV as recently as Q4 2022.

Canandaigua National Corp first reported a position in ABBV in Q2 2020 and has held it in 12 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Canandaigua National Corp held 27,988 shares of AbbVie worth $6.09M as of Q1 2026.
AbbVie was a new Canandaigua National Corp position in Q1 2026.
AbbVie made up 0.54% of Canandaigua National Corp's portfolio in Q1 2026, its #40 holding.
Canandaigua National Corp first reported a position in AbbVie in Q2 2020 and has held it in 12 quarters since.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.